Related Experiment Video
Updated: Jan 27, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Tankyrase1 antisense oligodeoxynucleotides suppress the proliferation, migration and invasion through Hippo/YAP
Yichi Zhou1, Qi Jin1, Wei Xiao1
1Department of Orthopaedics, CR & WISCO General Hospital, Wuhan, 430000, PR China.
Abstract:
Osteosarcoma is the most common malignant tumor of bone with a high potential for metastasis and poor prognosis. This study intends to explore the effect of tankyrase1 (TANK1) in the development of osteosarcoma cells and the underlying mechanism. The osteosarcoma cell line MG-63 cells were cultured and transfected with tankyrase1 antisense oligodeoxynucleotides (TANK1-ASODN). Cell proliferation was detected with CCK-8 and immunofluorescence. Cell migration and invasion were examined by wound healing assay and Transwell assay, respectively. Reverse transcription-quantitative polymerase chain reaction was performed to detect the mRNA level of TANK1 and western blot was conducted to detect relative protein expression during the research. As a result, we demonstrated that TANK1 was upregulated in osteosarcoma. The TANK1-ASODN inhibited MG-63 cell proliferation, migration and invasion. The progress of epithelial-mesenchymal transition (EMT) was also suppressed in TANK1-ASODN transfected MG-63 cells compared to control group. Besides, the TANK1-ASODN activated and modulated the Hippo/YAP signaling which might be the pathway that TANK1 depended on. Overall, our finding supported that TANK1-ASODN slowed down the progress of osteosarcoma by suppressing cell proliferation, migration, invasion and EMT through Hippo/YAP pathway.
Insights
Tankyrase1 (TANK1) is upregulated in osteosarcoma. Inhibiting TANK1 with TANK1-ASODN suppressed cancer cell growth, migration, and invasion, offering a potential therapeutic strategy for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Osteosarcoma is a primary bone cancer with high metastatic potential and poor patient outcomes.
- Understanding the molecular drivers of osteosarcoma progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of tankyrase1 (TANK1) in osteosarcoma development.
- To explore the therapeutic potential of targeting TANK1 in osteosarcoma cells.
Main Methods:
- Osteosarcoma MG-63 cells were transfected with tankyrase1 antisense oligodeoxynucleotides (TANK1-ASODN).
- Cell proliferation, migration, and invasion were assessed using CCK-8, immunofluorescence, wound healing, and Transwell assays.
- mRNA and protein levels of TANK1 were quantified using RT-qPCR and Western blot.
- The Hippo/YAP signaling pathway was analyzed.
Main Results:
- TANK1 expression was found to be upregulated in osteosarcoma cells.
- TANK1-ASODN transfection significantly inhibited MG-63 cell proliferation, migration, and invasion.
- Epithelial-mesenchymal transition (EMT) was suppressed in TANK1-ASODN treated cells.
- TANK1-ASODN modulated the Hippo/YAP signaling pathway.
Conclusions:
- TANK1 plays a significant role in promoting osteosarcoma progression.
- Inhibition of TANK1 via TANK1-ASODN demonstrates therapeutic promise by suppressing key cancer hallmarks.
- The Hippo/YAP pathway is implicated in the mechanism by which TANK1 influences osteosarcoma.
Related Concept Videos
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Cancer Cell Migration through Invadopodia

